Home/Pipeline/Cerene Endometrial Cryotherapy

Cerene Endometrial Cryotherapy

Heavy Menstrual Bleeding (Menorrhagia) and Dysmenorrhea

ApprovedCommercial

Key Facts

Indication
Heavy Menstrual Bleeding (Menorrhagia) and Dysmenorrhea
Phase
Approved
Status
Commercial
Company

About Channel Medsystems

Channel Medsystems, founded in 2003, is a commercial-stage medical device company addressing the significant unmet need in heavy menstrual bleeding (HMB), which affects 1 in 5 women. Its flagship product, the Cerene® Cryotherapy device, offers a quick, incision-free endometrial ablation performed in a physician's office without general anesthesia, supported by strong 3-year clinical data showing high efficacy and patient satisfaction. The company's mission is to empower women by providing a convenient, effective treatment that restores quality of life and control.

View full company profile

Therapeutic Areas